SILVER SPRING, Md., U.S.: As dental workflows continue to become increasingly digitally based, so, too, do certain regulatory processes. The U.S. Food and Drug Administration (FDA) has recently finalized a rule that removes requirements for multiple paper copies as part of the medical device submission process, instead replacing these with a single electronic submission.
According to the FDA, the regulation is, in part, a response to a 2017 Executive Order issued by President Donald Trump, which requires American government agencies to eliminate two regulations for each new regulation installed.
“FDA is amending current medical device regulations that require multiple copies and papdenter submissions to improve the efficiency of the review process by allowing immediate availability of an electronic version for review, rather than relying solely on the paper version,” the agency stated in a document outlining the changes.
“Because a submission in electronic format is easily reproducible, the requirement for multiple copies (whether in electronic format or paper form) is no longer necessary,” it continued.
To clear a medical device for commercial use in America, the manufacturer is required to submit a premarket notification 510(k) to the FDA with the goal of demonstrating that it is at least as safe and effective as a similar medical device that is already available for purchase. According to the FDA’s Medical Device Database, 227 dental devices have been granted clearance thus far in 2019.
Tags:
CANBERRA, Australia: A senate committee report recommending the passage of legislation that changes the way the Therapeutic Goods Administration (TGA) ...
ZURICH, Switzerland: Swiss-based start-up Odne has recently announced that it has received market clearance from the US Food and Drug Administration (FDA) ...
BRUSSELS, Belgium: In April, the European Parliament voted to implement a pair of new regulations concerning medical devices. First proposed in 2012 by the ...
SILVER SPRING, Md., US: The US Food and Drug Administration (FDA) has finalised guidance on animal studies for dental bone grafting material devices, aiming...
BEIJING, China: The Chinese State Council has announced its facilitation and expediting of the approval process for overseas pharmaceuticals and medical ...
BRUSSELS, Belgium: The European Parliament has voted to implement two new regulations concerning medical devices with the aim of improving safety in ...
Dear ADDE members and supporters, the first stakeholder meeting in Brussels on 23 February provided a great opportunity for promoting European dentistry and...
BRUSSELS, Belgium: After a three-year transition period and a delay of 12 months owing to the SARS-CoV-2 pandemic, new regulations now apply for medical ...
BASEL, Switzerland: The Straumann Group and botiss biomaterials have recently announced the opening of their collaborative research award, the Young Pro ...
ADDE considers the agreement on the EU medical device regulation a good compromise. With the new rules, the European level of safety in medicine and ...
Live webinar
Wed. 1 October 2025
1:00 pm EST (New York)
Live webinar
Thu. 2 October 2025
9:00 am EST (New York)
Live webinar
Mon. 6 October 2025
12:30 pm EST (New York)
Live webinar
Tue. 7 October 2025
12:30 pm EST (New York)
Prof. Dr. Falk Schwendicke MDPH
Live webinar
Thu. 9 October 2025
8:00 am EST (New York)
Dr. Priyantha Pang Lee Yek
Live webinar
Fri. 10 October 2025
5:00 am EST (New York)
Prof. Dr. Dr. Florian Stelzle
Live webinar
Fri. 10 October 2025
2:00 pm EST (New York)
To post a reply please login or register